Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1459-1466

  Eshleman, Amy J ^a,c   Stewart, Emilie ^a   Evenson, Anna K ^a   Mason, John N ^c   Blakely, Randy D ^d   Janowsky, Aaron ^a,b,c   Neve, Kim A ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catechol O methyltransferase; CDNA; Dopamine transporter; Tropolone

Indexed keywords

2' FLUORO 3,4 DIHYDROXY 5 NITROBENZOPHENONE; CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; CATECHOLAMINE; DOPAMINE; DOPAMINE TRANSPORTER; NORADRENALIN; SEROTONIN; TRITIUM; TROPOLONE;

ARTICLE; CATECHOLAMINE METABOLISM; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE; FIBROBLAST CULTURE; GLIOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

MAMMALIA; TRITIUM;

EID: 0030930379     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041459.x     Document Type: Article

References (30)

1. Belleau B. and Burba J. (1963) Occupancy of adrenergic receptors and inhibition of catechol O-methyl transferase by tropolones. J. Med. Chem. 6, 755-759.
2. Borgulya J., Bruderer H., Bernauer K., Zürcher G., and Da Prada M. (1989) Catechol-O-methyltransferase-inhibiting pyrocatechol derivatives: synthesis and structure-activity studies. Helv. Chim. Acta 72, 952-968.
3. Broch O. J. Jr. (1972) The in vivo effect of tropolone on dopamine metabolism and the catechol-O-methyl transferase activity in the striatum of the rat. Acta Pharmacol. Toxicol. 31, 217-225.
4. Broch O. J. Jr. and Fonnum F. (1972) The regional and subcellular distribution of catechol-O-methyl transferase in the rat brain. J. Neurochem. 19, 2049-2055.
5. Cass W. A., Zahniser N. R., Flach K. A., and Gerhardt G. A. (1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 61, 2269-2278.
6. Chen C. A. and Okayama H. (1988) Calcium phosphate-mediated gene tranfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6, 632-638.
7. Eshleman A. J., Henningsen R. A., Neve K. A., and Janowsky A. (1994) Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312-316.
8. Eshleman A. J., Neve R. L., Janowsky A., and Neve K. A. (1995) Characterization of a recombinant human dopamine transporter in multiple cell lines. J. Pharmacol. Exp. Ther. 274, 276-283.
9. Galli A., DeFelice L. J., Duke B.-D., Moore K. R., and Blakely R. D. (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198, 2197-2212.
10. Garris P. A. and Wightman R. M. (1995) Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striaturn of the rat in vivo. Synapse 20, 269-279.
11. Giros B., El Mestikawy S., Godinot N., Zheng K. Q., Han H., Yang-Feng T., and Caron M. G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390.
12. Gray E. G. and Whittaker V. P. (1962) The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived from homogenization and centrifugation. J. Anat. 96, 79-87.
13. Guldberg H. C. and Marsden C. A. (1975) Catechol-O-methyltransferase: pharmacological aspects and physiological role. Pharmacol. Rev. 27, 135-206.
14. Hansch C. and Leo A. J. (1979) Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley and Sons, New York.
15. Horn A. S. (1990) Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 34, 387-400.
16. Kilty J. E., Lorang D., and Amara S. G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579.
17. Morgenstern J. P. and Land H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
18. Pacholczyk T., Blakely R. D., and Amara S. G. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human nor-adrenaline transporter. Nature 350, 350-354.
19. Parish J. J. and Schenk J. O. (1996) Kinetic analyses of striatal dopaminergic transport in vitro: linkage to metabolism and vesicular sequestration. Soc. Neurosci. Abstr. 22, 370.
20. Pifl C., Giros B., and Caron M. G. (1993) Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13, 4246-4253.
21. 3H]GBR 12,935 binding. Mol. Pharmacol. 45, 125-135.
22. Ramamoorthy S., Bauman A. L., Moore K. R., Han H., Yang-Feng T., Chang A. S., Ganapathy V., and Blakely R. D. (1993) Anti-depressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90, 2542-2546.
23. Rivett A. J., Francis A., and Roth J. A. (1983) Distinct cellular localization of membrane-bound and soluble forms of catechol-O-methyltransferase in brain. J. Neurochem. 40, 215-219.
24. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
25. Trendelenburg U., Cassis L., Grohmann M., and Langeloh A. (1987) The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase. J. Neural Transm. Suppl. 23, 91-101.
26. van Horne C., Hoffer B. J., Stromberg I., and Gerhardt G. A. (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharmacol. Exp. Ther. 263, 1285-1292.
27. Wall S. C., Gu H., and Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47, 544-550.
28. Xu C., Coffey L. L., and Reith M. E. A. (1995) Translocation of dopamine and binding of 2β-carbomethoxy-3β-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers. Biochem. Pharmacol. 49, 339-350.
29. 3H] dopamine. Neuropharmacology 29, 475-486.
30. Zürcher G., Keller H. H., Kettler R., Borgulya J., Bonetti E. P., Eigenmann R., and Da Prada M. (1990) Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Adv. Neurol. 53, 497-503.